UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced encouraging safety ...

As with all products, the MHRA will keep its safety under close review. The Medicines and Healthcare products Regulatory ...

Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system's ability to ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

While chemotherapy, radiation and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some ...

Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit ...

Some patients diagnosed with certain types of cancer may soon have the options to skip chemotherapy, radiation and surgery in ...

A New England Journal of Medicine study published April 27 found success in administering dostarlimab, an immunotherapy drug, ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from ...

Additional support for the study was provided by the Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy, Swim Across America, imCORE-Genentech, the MacMillan Pathway to Independence ...

A new, small cancer study may give hope to patients with solid tumors in the stomach, esophagus or rectum. Read more trending ...

Generally, the standard treatment for solid tumors is surgery. However, a recent study from New York City-based Memorial Sloan Kettering Cancer Center found immunotherapy can effectively treat these ...